Pentostatin Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Pentostatin Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Aug 27, 2026. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-0801-01
Dosage Form
Injection
Presentation
Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)
Initial Posting
Aug 27, 2026

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.